Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Six More Weeks of Volatility?

If you haven’t heard, the groundhog saw his shadow, and if the snowfall on the East and West coasts weren’t enough of an indication, it looks like winter may be with us for awhile still … along with COVID and its variants, which are still a...

Failed Breakouts Take a Heavy Toll on the Oil Bulls

The bulls certainly made a strong run yesterday but didn’t finish the day on a strong note in the least. That’s an understatement, actually. They’ve given up almost all of their gains, closing below the many important resistances...

Buzz on the Bullboards: Making news, before it becomes a headline

Energy stocks slid on lower crude oil prices of late, keeping Canada’s resource-heavy main stock index on the lower side over the past few days, though the TSX has been pushing a rebound of...

Technical Analyst:Mega-Profitable Strategy for Next Heavy US Stock Market Down Leg Believed Imminent

Technical analyst Clive Maund discusses what he sees ahead for the markets. We are going to look at an array of important factors pointing to another severe drop in the broad U.S. stock market imminently, both factors external to it and indications on the charts fo...

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...

Leading Edge Materials: Positioning for the EU’s critical minerals push

By David Yeoman, Crux Investor Leading Edge Materials has a portfolio of critical raw materials projects in the EU, including the Norra Kärr heavy rare earths project in Sweden, the Woxna graphite mine in Sweden, and an exploration program in Romania. ...

Bloom Energy Shares Charge Higher on Partnership with Samsung for Clean Powered Ships

Shares of clean fuel cell technology company Bloom Energy traded 30% higher after the firm reported it is advancing plans for clean power ships in a joint development agreement with Samsung Heavy Industries. Solid oxide fuel cell technology company Bloom Energy Co...

Oil industry trailblazer Sara Akbar discusses her vision for Sonoro

The following is a transcription of the above video, and The Market Online has edited it for clarity . Following up on our recent conversation with Sonoro Energy Ltd. (TSXV:SNV) CEO Greg Renwick, we had the opportunity to spend some time with Director and Chairp...

Rich TV Live's Stocks to Watch this week (Dec. 1, 2023)

Richard De Sousa of the Rich TV Live podcast serves up his latest Stocks to Watch, exclusively for Stockhouse . De Sousa discusses heavy hitters like Amazon and Costco, but he also wants you to know about VVOS, RDHL, BDRX and a whole lot more. Check out the weekly ...

Changing Europe’s dependency on HREE from China

Leading Edge Materials (TSXV:LEM) provides North American investors a gateway to invest in Europe’s shift to self-sufficiency for critical raw materials. The company’s Norra Kärr project hosts one of the largest HREE deposits in the world...
1 2 3 4 5 6 7 8 9 10 ...